Hans Blokzijl

Hans Blokzijl is affiliated with the University of Groningen, specifically within the Faculty of Medical Sciences and the Translational Immunology Groningen (TRIGR) department. His work focuses on transplantation medicine, liver and kidney diseases, and immunological research. He contributes to the UN Sustainable Development Goals through medical advancements in healthcare quality and innovation.

Research Interests: His primary areas include liver transplantation outcomes, cohort analysis in transplant patients, nonalcoholic fatty liver disease mechanisms, and kidney transplant recipient outcomes. He collaborates internationally on projects like the TransplantLines biobank and cohort studies, emphasizing translational research.

Publications Trends: Recent work addresses liver stiffness as a diagnostic marker for amyloidosis, genetic factors in transplant rejection, and gut microbiome roles in liver disease. His studies often involve large-scale analyses and clinical cohort data.

He is part of collaborative networks such as the TransplantLines Investigators group, contributing to multi-center research on transplantation biology and outcomes. No specific awards are listed, but his work has been shared widely across academic platforms like Scopus and Mendeley.